Table 1. Screened deregulated miRNAs in males (n = 12) and females groups (n = 12).
| Down-regulated | Up-regulated | |||||
|---|---|---|---|---|---|---|
| Disease sample | miRNA | Log2(FC) | Padj | miRNA | Log2(FC) | Padj |
| Female-LUSC | miR-144 | -5.05 | 0.0012 | miR-205 | 7.31 | 2.59E-06 |
| miR-451 | -5.06 | 0.0012 | miR-1269 | 8.94 | 3.92E-06 | |
| miR-486 | -4.75 | 0.0025 | miR-210 | 5.18 | 0.0005 | |
| miR-30a | -3.09 | 0.0427 | miR-183 | 3.74 | 0.0230 | |
| miR-338 | -3.16 | 0.0433 | miR-9 | 6.79 | 0.0300 | |
| Male-LUSC | miR-451 | -4.19 | 6.81E-07 | miR-205 | 7.68 | 2.59E-22 |
| miR-30a | -3.23 | 4.48E-05 | miR-210 | 5.15 | 1.45E-05 | |
| miR-101 | -3.11 | 0.0002 | miR-183 | 3.27 | 9.68E-05 | |
| miR-30d | -3.03 | 0.0009 | miR-9 | 5.62 | 0.0026 | |
| miR-375 | -2.73 | 0.0023 | miR-203 | 2.24 | 0.0046 | |
| miR-140 | -2.63 | 0.0047 | miR-182 | 2.38 | 0.0078 | |
| miR-29c | -2.58 | 0.0060 | miR-141 | 2.05 | 0.0324 | |
| miR-100 | -2.25 | 0.0107 | ||||
| miR-143 | -2.09 | 0.0175 | ||||
| miR-181a | -2.22 | 0.0465 | ||||
| Female-THCA | miR-451 | -2.51 | 0.0002 | miR-183 | 2.67 | 9.42E-05 |
| miR-486 | -2.40 | 0.0002 | miR-221 | 2.70 | 0.0006 | |
| miR-144 | -2.26 | 0.0005 | miR-182 | 2.35 | 0.0012 | |
| Male-THCA | miR-146b | 5.97 | 4.69E-05 | |||
| miR-221 | 3.29 | 0.0279 | ||||
Note: The sample size is selected according to the actual distribution of females and males in the normal sample, and the relevant selected individuals are collected according to the principle of homogeneous.